American Academy of Pediatrics. Committee on Drugs. Use of codeine- and dextromethorphan-containing cough syrups in pediatrics.
D000293:Adolescent; D000818:Animals; D000996:Antitussive Agents / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D003061:Codeine / Q000008:administration & dosage* / Q000009:adverse effects / Q000378:metabolism; D003371:Cough / Q000188:drug therapy; D003915:Dextromethorphan / Q000008:administration & dosage* / Q000009:adverse effects; D004155:Diphenhydramine / Q000009:adverse effects / Q000627:therapeutic use; D004338:Drug Combinations; D004349:Drug Packaging; D006801:Humans; D007223:Infant; D007981:Levorphanol / Q000031:analogs & derivatives*; D008297:Male; D009294:Narcotics / Q000627:therapeutic use; D010372:Pediatrics; D012955:Societies, Medical; D014481:United States
D000996:Antitussive Agents; D004338:Drug Combinations; D009294:Narcotics; D007981:Levorphanol; D003915:Dextromethorphan; D004155:Diphenhydramine; D003061:Codeine